Nanollose Ltd (ASX:NC6) Quarterly Update
Nanollose Limited (ASX:NC6) is pleased to provide its Appendix 4C cash flow statement for the quarter ending 30 September 2018, together with the following operational update.
Companies in the News
Biotech
Rhinomed Limited (ASX:RNO) Business Update - FY19 Q1 September Quarterly Report
Rhinomed (ASX:RNO) (OTCMKTS:RHNMF) a leader in nasal delivery technology, today announced its 7th consecutive quarter on quarter of revenue growth. Positive trading conditions saw unaudited recognised revenues increase 30% over FY18 Q4 to $1.14m for FY19 Q1.
Anatara Lifesciences Ltd (ASX:ANR) Quarterly Report
Anatara Lifesciences (ASX:ANR) is pleased to release its Appendix 4C for the quarter ending 30th September 2018. The Company's cash position at the end of the quarter stood at $7.1m.
Nanollose Ltd (ASX:NC6) Successful Garment Made from Sustainable Nullarbor Fibre
Nanollose Limited (ASX:NC6) is pleased to provide more information around the successful creation of a test garment made from the Company's Nullarbor(TM) fibre. This marks the first time a piece of clothing has been made using our Tree-Free rayon fibre, and is a drastic departure from clothing made from traditional rayon fibre that comes from environmentally challenging wood pulp processing.
Anatara Lifesciences Ltd (ASX:ANR) APVMA Approval for Detach
Anatara Lifesciences (ASX:ANR) is pleased to announce that the Australian Pesticides and Veterinary Medicines Authority has registered Detach(R) with the approved label, "To aid in the control of scour and has positive health benefits in weaned piglets from 3 weeks of age and help increase survivability of scouring pre-weaning piglets".
Nanollose Ltd (ASX:NC6) 2018 AGM & Presentation
Nanollose Limited (ASX:NC6) reminds shareholders that its 2018 Annual General Meeting will be held at 1:00pm WST on Monday, 29 October 2018 at its registered office.
Nanollose Ltd (ASX:NC6) to Access Additional R&D Rebates on Overseas Expenditure
Nanollose Limited (ASX:NC6) is pleased to announce that it has obtained favourable findings from the Department of Industry, Innovation and Science which will enable the Company to claim tax rebates on certain overseas research and development expenditure up to $1.419 million over the next three years.
◂Previous Page
Biotech Next Page▸
Banking & Finance
- VIDEO: Lion Selection Group Ltd (ASX:LSX) CEO Hedley Widdup and Sean Russo Talk at the Australian Gold Conference 2024
- VIDEO: The Australian Gold Conference 2024 - Education Evening with Expert Panel
- Lithium Universe Ltd (ASX:LU7) Finalises Frankfurt and US OTC Listing
Social Media
